Net Cash Provided by (Used in) Operating Activities in USD of 10x Genomics, Inc. from 2017 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
10x Genomics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2017 to Q1 2025.
- 10x Genomics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $34.4M.
- 10x Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $6.66M.
- 10x Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$15.2M, a 54.8% increase from 2022.
- 10x Genomics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$33.6M, a 57.2% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)